Tobramycin has proved to be a useful agent in the chemotherapy of gram-negative aerobic infections (2, 11) . However, studies in animals and humans have revealed a narrow toxic/therapeutic ratio (2) . Furthermore, serum levels adequate to cure major infections must be achieved (11) . Although serum levels are predictable in healthy, male volunteers used to evaluate the initial clinical pharmacology of aminoglycosides, the long terminal phase of excretion and patient variation cause serum levels-to be less predictable during multiple-dose therapy of infection (7, 16) . Thus, as with gentamicin, there is a need to monitor serum levels of tobramycin (13) .
Bioassays of serum levels of aminoglycosides are reliable if careful attention is given to problems inherent in these assays (15) . However, the results are usually not available as rapidly as needed to make dosage adjustments. Other assays, including radioimmunoassay (RIA), radioenzymatic assays (utilizing adenylating or acetylating enzymes), spectrofluorometry, gasliquid chromatography, and high-pressure liquid chromatography, have been developed (1, 3, 6, (8) (9) (10) 17) . These techniques, however, have problems attendant with their use (1, 3, 6, (8) (9) (10) 17) .
Homogenous enzyme immunoassay (EIA) was introduced in 1972 (14) . The technique has been utilized widely to monitor serum levels of antiepileptic agents, asthma medications, and cardiac drugs and to monitor thyroid function (4, 5) . Recently, a study in our laboratory demonstrated the accuracy and usefulness of the EIA technique in assaying serum gentamicin levels (12 Reagents for the EIA study were obtained from Syva Corp., Palo Alto, Calif. The method employs a bacterial glucose 6-phosphate dehydrogenase enzyme to which tobramycin has been linked. The active site of the enzyme is adjacent to the bound aminoglycoside. Antitobramycin antibody wiil bind to the tobramycin adjacent to the enzyme, thereby decreasing enzymatic activity. The assay follows the conversion of nicotinamide adenine dinucleotide to reduced nicotinamide adenine dinucleotide, which occurs when the enzyme acts on a substrate. Free tobramycin in standards or from a sample competes for antibodies with drug bound to the enzyme. When less antibody blocks the active site of the glucose 6-phosphate dehydrogenase, the activity of the enzyme is increased. Standards of tobramycin were prepared in serum. 
DISCUSSION
Clinically, the measurement of serum tobramycin levels is of value if the result is returned to the physician rapidly (11, 17 and a prior study, we found that setup time for the first sample by RIA is 1 h and 35 min, with 5 to 10 min needed for each additional test (12) . In addition, the RIA requires special skill and equipment and yields radioactive waste. Aithough a rapid biological method for measurement of tobramycin has been developed, it also requires some time to set up and then at least 2.5 h before reading (17) . Other methods, including radioenzymatic assay and spectrofluorome- tric assays, also require special equipment and skill, and all but the RIA require horse or human serum for dilution of test sera and standards in addition to special reagents (1, 3, 6, 8, 9, 10, 17) . Finally, commercially available reagent kits for RIA of tobramycin have a shelf life of only about 1 month.
The EIA method for determining tobramycin levels required a set up time of 25 to 30 min, with 2 min needed for each additional sample. The standard curve was reproducible during the working day, so that samples could be run at any time during the day. Delay time between obtaining the sample and return of assay results to the physician may be 30 min, very acceptable for decision making. In addition, the test could be performed on standard equipment available in many laboratories, with little special skill required of the operator. No diluting sera are required, and samples and standards are stable at 4°C and -20°C, respectively, for periods considerably longer than 1 month (up to 6 months in our study). No radioactive wastes are produced, and only 50 pd of serum is required per assay. This latter fact makes the assay particularly useful in pediatric situations. Precision and specificity of the EIA and RIA were similar. Accuracy ofthe EIA was better than RIA in this study, however. Variation of 25% within 95% confidence limits has been considered acceptable and is probably more so in face of variation of 32% with the commerically available RIA method used in this study (13) . Thus, for laboratories already using the same instrumentation to measure other drugs, EIA would be a preferable method for determining tobramycin levels.
It has already been shown to be so for determining gentamicin levels (12) . For other laboratories EIA offers a viable alternative to currently available methods for determining tobramycin serum levels. The greatest value of the EIA is to provide a means to rapidly adjust dosage programs for critically il patients. Neither the RIA nor the microbiological method, albeit accurate and VOL. 13, 1981 on November 2, 2017 by guest http://jcm.asm.org/ Downloaded from precise, has aided our group in adjusting the dosage programs of aminoglycosides in patients with rapidly changing renal function, whereas the EIA has.
